BioPharma
Manufacturing Solutions Inc.
June 17, 2014
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention:Jay Ingram, Legal Branch Chief
Re: | BioPharma Manufacturing Solutions, Inc. Form S-1 Registration Statement (Registration No. 333-184494), originally filed October 18, 2012, as amended |
Acceleration Request
Requested Date: | June 18, 2014 | |
Requested Time: | 4:01 PM Eastern Time |
Ladies and Gentlemen:
BioPharma Manufacturing Solutions, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-1 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
• | should the Commission or the staff of the Commission, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; |
• | the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and |
• | the Registrant may not assert the staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
8001 Irvine Center Drive, Suite 400 | Phone: 562-244-9785 |
Irvine, CA 92618 | Fax: 562-493-0743 |
BioPharma
Manufacturing Solutions Inc
Thank you for your assistance.
Sincerely, | ||
BIOPHARMA MANUFACTURING SOLUTIONS, INC. | ||
By: | /s/ Gary Riccio | |
Gary Riccio | ||
Chief Executive Officer |
cc: Steven J. Davis, Esq.
8001 Irvine Center Drive, Suite 400 | Phone:562-244-9785 |
Irvine, CA 92618 | Fax: 562-493-0743 |